Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Journal article |
| Publicado: |
2012
|
| _version_ | 1826282996635795456 |
|---|---|
| author | Chakravarthy, U Harding, S Rogers, C Downes, S Lotery, A Wordsworth, S Reeves, B |
| author_facet | Chakravarthy, U Harding, S Rogers, C Downes, S Lotery, A Wordsworth, S Reeves, B |
| author_sort | Chakravarthy, U |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T00:52:16Z |
| format | Journal article |
| id | oxford-uuid:86cab83c-050b-40d0-8c05-983f0d97d097 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T00:52:16Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:86cab83c-050b-40d0-8c05-983f0d97d0972022-03-26T22:06:26Z Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular DegenerationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:86cab83c-050b-40d0-8c05-983f0d97d097Symplectic Elements at Oxford2012Chakravarthy, UHarding, SRogers, CDownes, SLotery, AWordsworth, SReeves, B |
| spellingShingle | Chakravarthy, U Harding, S Rogers, C Downes, S Lotery, A Wordsworth, S Reeves, B Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title_full |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title_fullStr |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title_full_unstemmed |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title_short |
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration |
| title_sort | ranibizumab versus bevacizumab to treat neovascular age related macular degeneration |
| work_keys_str_mv | AT chakravarthyu ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT hardings ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT rogersc ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT downess ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT loterya ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT wordsworths ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration AT reevesb ranibizumabversusbevacizumabtotreatneovascularagerelatedmaculardegeneration |